Essential Oil Aromatherapy Intervention
1 other identifier
interventional
33
1 country
1
Brief Summary
Lab sampling for clinical trial participants can be a stressful and painful experience. Most trial participants will have blood drawn for lab samples at multiple study visits. The participants must fast for up to ten hours before the blood sampling, in many cases, and patients often report a painful experience if more than one venipuncture occurs. In addition, the number of collection tubes can increase the anxiety level of the patient and the phlebotomist. This project proposes to evaluate if essential oil aromatherapy results in less pain and /or anxiety when compared to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 2, 2016
CompletedFirst Posted
Study publicly available on registry
May 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFebruary 27, 2018
February 1, 2018
1.6 years
May 2, 2016
February 23, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Pain Scores
At the time of study enrollment and again upon completion at 6 months
Change in Anxiety Scores
At the time of study enrollment and again upon completion at 6 months
Secondary Outcomes (2)
Number of venipunctures needed to collect required sample
At the time of study completion at 6 months
Number of blood collection tubes required for sample
At the time of study completion at 6 months
Study Arms (2)
Aromatherapy
EXPERIMENTALThe participants randomized to aromatherapy will be offered one of three essential oils, 'applied' to their smell zone via cotton ball that are known to have anti-anxiety effect. These are: * ginger * calming * lavender The participant's choice will be documented in a database. The participant can chose an oil each time (i.e., they are not bound to use only the first choice oil). Pain and anxiety will be measured prior to receiving the essential oils and again after the phlebotomy procedure. Blood pressure and pulse will also be measured post-phlebotomy.
Standard of Care
NO INTERVENTIONThe participants randomized to standard of care will proceed to the outpatient phlebotomy room in the Heart Care Clinic as per usual care. Pain, anxiety, blood pressure and pulse will be assessed pre and post-procedure.
Interventions
Participants in this arm will be offered one of three essential oils: ginger, lavender or calming
Eligibility Criteria
You may qualify if:
- Must be at least 18 years of age
- Must be currently participating in a clinical trial at HealthEast
You may not qualify if:
- Known allergy to any of the oils used for aromatherapy
- Less than age 18
- Declined to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HealthEast Clinical Trials Office
Saint Paul, Minnesota, 55104, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beth Jorgeonson, RN, BSN
HealthEast Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2016
First Posted
May 6, 2016
Study Start
May 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
February 27, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share
Study results will be shared with the organization and submitted for publication. Individual participant data will not be shared.